Erin K Barr

Trials

Studies that name Erin K Barr as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 11:27 UTC. Open this list on ClinicalTrials.gov

• Ph1
  NCT06894979 · Testing the Addition of an Anti-Cancer Drug, AZD1390, During Radiation Therapy for Newly Diagnosed High Grade Glioma, Diffuse Midline Glioma, or Diffuse Intrinsic Pontine Glioma

  Children's Oncology Group · active not recruiting · Childhood Astrocytoma, Childhood Diffuse Intrinsic Pontine Glioma, Childhood Diffuse Midline Glioma · principal investigator
• Ph1
  NCT02013336 · Phase 1 Dose-escalating Study of MM-398 (Irinotecan Sucrosofate Liposome Injection) Plus Intravenous Cyclophosphamide in Recurrent or Refractory Pediatric Solid Tumors

  South Plains Oncology Consortium · recruiting · Recurrent or Refractory Solid Tumors, Ewing Sarcoma, Rhabdomyosarcoma · study chair

Grants

NIH projects from RePORTER, fetched 2026-11-12 11:27 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. 6 other NIH projects list an investigator with the same name at a different institution and are left out. Coverage is US federal funding only; UK and EU funders are not searched yet.

No NIH project could be tied to this name by a shared trial or a matching institution.

NIH grants that fund their trials

These grant numbers are on the registry records of the trials above. They fund the trial, often through a cooperative group or network, and their principal investigator is usually someone else.

• Pediatric Early Phase Clinical Trials Network (PEP-CTN) Transfer Application
  UM1CA228823 · NCI · COG RESEARCH FOUNDATION, LLC · PI Elizabeth Fox · fiscal years 2018 to 2026
  Named on NCT06894979